Journal of Clinical Biochemistry and Nutrition
Online ISSN : 1880-5086
Print ISSN : 0912-0009
ISSN-L : 0912-0009
Original Articles
Effectiveness of the serum ratio of L-cysteine to glutathione for the prediction of cardiovascular events
Yuki Ishinoda, Nobuyuki Masaki, Yasuhiro Hitomi, Ryota Nakazawa, Akira Taruoka, Akane Kawai, Midori Iwashita, Yasuo Ido, Yusuke Yumita, Kazuki Kagami, Risako Yasuda, Yukinori Ikegami, Takumi Toya, Yuji Nagatomo, Bonpei Takase, Takeshi Adachi
Author information
JOURNAL OPEN ACCESS
Supplementary material

2025 Volume 77 Issue 2 Pages 174-181

Details
Abstract

Aminothiols play an important role in the antioxidant defense system. Their serum profile may be a predictor of prognosis and cardiovascular events. This study followed-up 262 patients (202 ‍men; age, 65 ‍± 13 years) who had been treated for cardiovascular disease. The patients were divided into two groups by the median total l-cysteine to total glutathione (tCySH/tGSH) ratio in serum at enrollment. There were 32 (11%) all-cause deaths, 20 (8%) cardiovascular deaths, and 32 (12%) major cardiovascular events in 5.5 ‍± 3.2 years. Twenty-nine (11%) patients were hospitalized for heart failure. The high tCySH/tGSH ratio group (≥80.70) had a higher incidence of all-cause death than the low tCySH/tGSH ratio group (<80.70; log-rank test, p = 0.025). Multivariate Cox regression analysis adjusted for age, sex, body mass index, current smoking, renal function, and log10-transformed brain natriuretic peptide showed that the tCySH/tGSH ratio had predictive value for all-cause death, cardiovascular death, and heart failure. The adjusted hazard ratio for heart failure for the high versus low tCySH/tGSH ratio groups was 3.071 (95% confidence interval: 1.186–7.952; p = 0.021). The tCySH/tGSH ratio may be an useful biomarker to assess prognosis, cardio­vascular events, and heart failure.

Content from these authors
© 2025 JCBN

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top